3D Bioprinting Uses Engineered Living Materials to Mimic Nature

• Researchers under the EU-funded PRISM-LT project are developing a 3D bioprinting platform to create Engineered Living Materials (ELMs).
• Unlike static materials, ELMs utilize living cells and microorganisms that can self-organize, adapt, and repair.
• The technology uses encapsulated "living building blocks" containing cells and bioink, guided by genetically engineered microbes that release growth factors to direct stem cell development.

Technical Process and Goals

• The manufacturing phase takes minutes to an hour, followed by a three-week maturation period where stem cells develop into specific tissues like bone, muscle, or fat.
• Current capabilities allow for the production of one square centimeter of thin tissue, with ongoing work toward one cubic centimeter blocks.
• A core challenge is establishing a symbiotic environment where disparate systems, such as yeast and stem cells, can survive and differentiate simultaneously.

Applications and Impact

• Biomedical Research: Creating 3D bone marrow models to study diseases like leukaemia and developing organ mimics for drug testing and personalized medicine.
• Food Production: Using bioprinting to replicate the fat-streak structures found in conventional meat, which provides the desired texture and flavor currently lacking in cultivated meat.
• Public Perception: Researchers are prioritizing the use of yeast rather than bacteria for food applications to increase consumer acceptance.

Future Challenges and Regulation

• Regulatory Hurdles: Because ELMs are "alive" and often contain genetically modified organisms, they do not fit existing regulatory frameworks for food or medicine.
• Collaboration: The PRISM-LT team is working with the European Medicines Agency to establish new safety pathways and regulatory standards.
• Scalability: While the project has proven the feasibility of the technology, scaling production to real-world application levels remains the primary future objective.